| Patents for C07D 215 - Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems (27,676) |
|---|
| 08/08/2002 | WO2002060423A2 Substituted carbostyril derivatives as 5-ht1a receptor subtype agonists |
| 08/08/2002 | WO2002024650A3 Pyridinone and pyridinethione derivatives having hiv inhibiting properties |
| 08/08/2002 | WO2002018327A3 Guanidinobenzamides as mc4-r agonists |
| 08/08/2002 | WO2002014269A3 2,4-substituted pyridine derivatives |
| 08/08/2002 | WO2002006189A3 Aniline derivatives |
| 08/08/2002 | WO2002002518A3 Compounds to treat alzheimer's disease |
| 08/08/2002 | WO2001085664A3 Compounds and methods for regulating bacterial growth and pathogenesis |
| 08/08/2002 | US20020107406 Calcium receptor-active compounds |
| 08/08/2002 | US20020107396 3-cycloalkyl- or propyl-2-(3,4-dihalophenyl)-N-quinolinyl-, quinazolinyl-, or quinoxolinyl-propionamide. |
| 08/08/2002 | US20020107345 Complex of a selected transition metal with a monoanionic ligand that has at least three atoms that may coordinate to the transition metal, one of which is an oxygen at and one of which is a nitrogen in an imine radical |
| 08/08/2002 | US20020107241 N-heterocyclic derivatives useful for treating or preventing neuronal damage associated with neurological disease |
| 08/08/2002 | US20020107207 2,5,7,8-tetramethyl-2R-(4,8,12-trimethyl-3,7,11 E:Z tridecatrien)chroman-6-yloxy) acetic acid for example; use as antiproliferative agent |
| 08/08/2002 | CA2672805A1 Pyrimidine derivatives |
| 08/07/2002 | EP1229035A1 Imine intermediates for the preparation of trisubstituted imidazole compounds with multiple therapeutic properties |
| 08/07/2002 | EP1229019A1 Process for the production of optically active cyclic enaminone derivatives |
| 08/07/2002 | EP1228066A2 Sulfonamide derivatives |
| 08/07/2002 | EP1228060A1 Arylalkane, arylalkene and aryl azaalkane, medicaments containing said compounds and method for the production thereof |
| 08/07/2002 | EP1228042A2 Tetrahydroquinoline derivatives having retinoid-like biological activity |
| 08/07/2002 | EP1228039A1 N-guanidinoalkylamides, their preparation, their use, and pharmaceutical preparations comprising them |
| 08/07/2002 | EP1228024A1 Novel hydronaphtalene compounds, prepared by a rhodium catalyzed ring opening reaction in the presence of phosphine ligand |
| 08/07/2002 | EP0801649B1 Hydroxylamine derivatives useful for enhancing the molecular chaperon production and the preparation thereof |
| 08/07/2002 | CN1362947A N-cyanomethylamides as protease inhibitors |
| 08/07/2002 | CN1088709C Amine compound and its acid addition salt |
| 08/06/2002 | US6429317 Indane derivatives for antipsychotic compositions |
| 08/06/2002 | US6429214 Inhibitors of bone resorption |
| 08/06/2002 | US6429213 Cyclic hydroxamic acids as metalloproteinase inhibitors |
| 08/06/2002 | US6429207 Metabotropic glutamate receptor antagonists and their use for treating central nervous system diseases |
| 08/01/2002 | WO2002059239A2 Lubricating oil composition with improved soot dispersing properties comprising an aromatic oligomer |
| 08/01/2002 | WO2002059122A1 ANTI-CANCER 2,3-DIHYDRO-1H-PYRROLO[3,2-f]QUINOLINE COMPLEXES OF COBALT AND CHROMIUM |
| 08/01/2002 | WO2002059094A1 A new process for preparing a quinolone-carboxylic acid |
| 08/01/2002 | WO2002059076A1 Method for producing dtpa monoamides |
| 08/01/2002 | WO2002059074A1 Benzylamine analogue |
| 08/01/2002 | WO2002058703A2 The treatment of sexual dysfunction and cardiovascular disease with quinolinone enantiomers |
| 08/01/2002 | WO2002058702A1 Urotensin-ii receptor antagonists |
| 08/01/2002 | WO2002058695A1 (halo-benzo carbonyl)heterocyclo fused phenyl p38 kinase inhibiting agents |
| 08/01/2002 | WO2002012190A3 Non-imidazole aryloxypiperidines as h3 receptor ligands |
| 08/01/2002 | WO2002002505A3 Compounds to treat alzheimer's disease |
| 08/01/2002 | WO2001078697A3 Method and compositions for the treatment of allergic conditions using pgd2 receptor antagonists |
| 08/01/2002 | US20020103241 Such as N-benzooxazol-2-yl-3-cyclopentyl-2-(4-methanesulfonyl -phenyl)-propionamide for increasing insulin secretion in the treatment of type II diabetes |
| 08/01/2002 | US20020103239 Such as N-hydroxy-2-(((4-phenoxyphenyl)-sulfonyl)methyl) benzamide which inhibits matrix metalloprotease activity |
| 08/01/2002 | US20020103234 Heterocycl-containing carboxylic acid derivative and drug containing the same |
| 08/01/2002 | US20020103226 Substituted 8-arylquinoline phosphodiesterase-4 inhibitors |
| 08/01/2002 | US20020103220 Such as N-(4-chlorobenzyl)-6-(4-morpholinylmethyl)-4-oxo-1-phenyl-1,4- dihydro-3-quinolinecarboxamide for treatment of herpes virus; viral DNA polymerase inhibitors |
| 08/01/2002 | US20020103214 Novel heteroaryl derivatives and their use as medicaments |
| 08/01/2002 | US20020103203 For treating cancer and other disease states associated with unwanted angiogenesis and/or cellular proliferation such as diabetic retinopathy, neovascular glaucoma, rheumatoid arthritis, psoriasis |
| 08/01/2002 | US20020103199 Fused heteroaromatic glucokinase activators |
| 08/01/2002 | US20020103192 Perfluoroalkylketones, ketooxazoles, ketoamides, ketoesters, and diketones, and their dihydroxy derivatives, such as 7-((1,1'-biphenyl)-3-yloxy)-1-(1,3-oxazol-2-yl)-1-heptanone |
| 08/01/2002 | CA2435883A1 Benzylamine analogue |
| 08/01/2002 | CA2435876A1 The treatment of sexual dysfunction and cardiovascular disease with quinolinone enantiomers |
| 08/01/2002 | CA2435653A1 Anti-cancer 2,3-dihydro-1h-pyrrolo[3,2-f]quinoline complexes of cobalt and chromium |
| 08/01/2002 | CA2431904A1 (halo-benzo carbonyl)heterocyclo fused phenyl p38 kinase inhibiting agents |
| 07/31/2002 | EP1227092A2 Isonitrile intermediates for the preparation of tri-substituted imidazole compounds with multiple therapeutic properties |
| 07/31/2002 | EP1227091A2 Formamide intermediates for the preparation of tri-substituted imidazole compounds with multiple therapeutic properties |
| 07/31/2002 | EP1226137A1 Phenyl- and pyridyl-tetrahydro-pyridines having tnf inhibiting activity |
| 07/31/2002 | EP1226108A1 Diaryl-enynes |
| 07/31/2002 | EP0854867B1 Tetrahydroquinolines as nmda antagonists |
| 07/31/2002 | CN1361768A Metabotropic glutamate receptor antagonists and their use for treating central nervous system diseases |
| 07/31/2002 | CN1360890A Use of active retiene derivative with negative hormone and/or antagonist |
| 07/30/2002 | US6426364 Nervous system or psychological disorders |
| 07/30/2002 | US6426349 Substituted condensation products of N-benzyl-3-indenylacetamides with heterocyclic aldehydes for neoplasia |
| 07/30/2002 | CA2056619C Method of inactivation of viral and bacterial blood contaminants |
| 07/25/2002 | WO2002057256A1 Piperazinylcarbonylquinolines and -isoquinolines |
| 07/25/2002 | WO2002057238A1 Substituted quinolines for the treatment of protozoan and retrovirus co-infections |
| 07/25/2002 | WO2002057220A1 Hydrazide derivatives and pharmaceutical compositions containing same |
| 07/25/2002 | WO2002057215A2 Sodium channel modulators |
| 07/25/2002 | WO2002032874A3 Substituted heterocyclic compounds for treating multidrug resistance |
| 07/25/2002 | WO2002032845A3 Method of producing carboxylic acid salts |
| 07/25/2002 | US20020099224 Hydrolysis of [R (R*, R*)]-2-(4-fluorophenyl)-beta,delta-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoic acid esters with calcium hydroxide |
| 07/25/2002 | US20020099215 For therapy and prophylaxis of P-glycoprotein-mediated multidrug resistance |
| 07/25/2002 | US20020099213 Dissolving 6-hydroxy-3,4-dihydroquinolinone and a base in water; dissolving a 1-cyclohexyl-5- (4-halobutyl)-tetrazole in water-immiscible solvent, mixing aqueous phase and organic phase in presence of phase transfer catalyst; recovering |
| 07/25/2002 | US20020099212 Sulfonamide compounds and pharmaceutical use thereof |
| 07/25/2002 | US20020099096 Useful for oral testosterone replacement therapy, male contraception, maintaining sexual desire in women, treating prostate cancer and imaging prostate cancer |
| 07/25/2002 | US20020099089 Administering compounds such as trans-3-(naphth-2-yl)-but-2-enoic acid-N-(2-carboxy-phenyl)-amide or like for therapy of conditions associated with increased telomerase activity, e.g. tumour diseases |
| 07/25/2002 | US20020099084 Pharmaceutically active compounds and methods of use |
| 07/25/2002 | US20020099048 Bicycloloactam compounds, use thereof and intermediates for preparing thereof |
| 07/24/2002 | EP1224187A2 Certain alkylene diamine-substituted heterocycles |
| 07/24/2002 | EP1224172A1 Drugs for the treatment of malignant tumours |
| 07/24/2002 | EP1224165A1 Novel compounds |
| 07/24/2002 | EP1223935A1 Methods of use of fluoroquinolone compounds against bacteria |
| 07/24/2002 | EP1223921A2 Tissue factor antagonists and methods of use thereof |
| 07/24/2002 | EP1102743B1 Amide derivatives which are useful as cytokine inhibitors |
| 07/24/2002 | EP0988045A4 Peptide nucleic acid monomers and oligomers |
| 07/24/2002 | EP0966473B1 Thiazolobenzoheterocycles, preparation and medicines containing same |
| 07/24/2002 | EP0922034B1 Tetrahydroquinoline derivatives as eaa antagonists |
| 07/24/2002 | EP0684945B1 Pyrazole- or isoxazole-substituted alkyl amide acat inhibitors |
| 07/24/2002 | CN1360582A Quinazoline derivs. |
| 07/24/2002 | CN1360498A Carboxylic acid derivs. that inhibit binding of integrins to their receptors |
| 07/23/2002 | US6423717 Nervous system disorders |
| 07/23/2002 | US6423690 Antibacterial agents |
| 07/18/2002 | WO2002055516A2 1,1-DISUBSTITUTED CYCLIC INHIBITORS OF MATRIX METALLOPROTEASE AND TNF-$g(a) |
| 07/18/2002 | WO2002055014A2 Therapeutic chroman compounds |
| 07/18/2002 | WO2002055013A2 Therapeutic chromone compounds |
| 07/18/2002 | WO2002055012A2 Therapeutic heterocyclic compounds |
| 07/18/2002 | WO2002042250B1 DERIVATIVES OF 4-HYDROXYBUTANOIC ACID AND OF ITS HIGHER HOMOLOGUE AS LIGANDS OF η-HYDROXYBUTYRATE (GHB) RECEPTORS, PHARMACEUTICAL COMPOSITIONS CONTAINING SAME AND PHARMACEUTICAL USES |
| 07/18/2002 | WO2002016310A9 Selective androgen receptor modulators and methods of use thereof |
| 07/18/2002 | WO2002012224A3 Bicyclic compounds as h3 receptor ligands |
| 07/18/2002 | WO2002000625A3 Process for the preparation of quinoline derivatives |
| 07/18/2002 | WO2002000623A3 Aryl fused substituted 4-oxy-pyridines |
| 07/18/2002 | WO2001072685A3 Polyamine analogues as cytotoxic agents |
| 07/18/2002 | US20020095039 Guanidinylamino heterocycle compounds useful as alpha-2 adrenoceptor agonists |